GNRH1 and posterior cortical atrophy: In vivo evidence of the non-pituitary-mediated effect on prostate is demonstrated by the inhibition of the growth of androgen-independent PCa xenografts (DU145 cells) in nude mice treated with a GnRH agonist, Zoladex [20].